Introduction
The current lifestyle of people, mainly in developed countries, is connected with so-called diseases of civilization. These diseases include a large group of cardiovascular diseases, obesity, hypertension, type 2 diabetes, tumor diseases, autoimmune diseases, osteoporosis, and psychiatric disorders. Nowadays, life expectancy is increasing, but many patients suffer from various age-related and degenerative diseases that are also influenced by current lifestyle (i.e. diet, exercise, smoking, alcohol, and mental stress). Age-related and degenerative diseases can be mitigated and sometimes prevented by changing the patient's habits, but pharmacotherapy often becomes necessary. However, in situations where pharmacotherapy is not sufficient, and severe complications occur, tissue replacement can be essential.
This review is focused on current and future ways to replace damaged bone and blood vessel tissues, especially with the use of suitable adult mesenchymal stem cells as a potential source of differentiated mature cells that can later be used for tissue replacement.
Bone anatomy and physiology
Bone is a compact tissue consisting of cancellous and cortical bone. Most of the bone tissue consists of extracellular matrix. The bone extracellular matrix is a mass of tissue (mainly organic component type I collagen and inorganic component hydroxyapatite) that surrounds and supports bone cells. Type I collagen provides tensile strength, and hydroxyapatite provides compressive stiffness (Reichert et al. 2016) . Besides these main components, the extracellular matrix contains proteoglycans and glycosylated proteins. Each of the proteins has a role in influencing bone mineral deposition and in regulating the cell activity (for a review, see Clarke Both in childhood and in adult age, the bone underlies the remodelling cues in a dynamic response to physiological influences and mechanical forces (Clarke 2008) . Briefly, during the remodelling process, the old cells are resorbed (over a period of 2-3 weeks) and new bone tissue is formed (over a period of 2-3 months) to keep mineral homeostasis stable (Reichert et al. 2016) . In the first phase, osteoclast formation and activation is regulated by receptor activator NF-κB ligand (RANKL), osteoprotegrin, proteins of the interleukin family, colonystimulating factors (CSF), parathyroid hormone, 1,25-dihydroxyvitamin D, and calcitonin (Clarke 2008, Martin and Seeman 2008) . Subsequent bone tissue formation is influenced and regulated by bone matrix-derived factors, such as insulin-like growth factor (IGF) I and II, acidic and basic fibroblast growth factor (FGF), transforming growth factor β (TGF-β) 1 and 2, bone morphogenetic proteins (BMPs) 2, 3, 4, 6, and 7, platelet-derived growth factor (PDGF), and potentially other molecules (Bonewald et al. 1990 , Clarke 2008 , Martin and Seeman 2008 .
Pathophysiology of degenerative bone damage
Osteoarthritis (and one of its important types, i.e., osteoarthrosis) is an age-associated chronic degenerative disorder of cartilage and bone that affects many patients all over the world. The hip and knee joints are most often affected, due to loading during activities of daily living (Kutzner et al. 2010) . The risk factors of osteoarthritis include age, microtrauma injury damage, an inflammation insult, obesity, or genetic predispositions (Loeser et al. 2016) .
Although the loss of articular cartilage has been reported as the first set of changes, it is now clear that a second set of changes also affects subchondral bone, bone marrow, synovium, menisci, ligaments and periarticular muscles (for a review, see Man and Mologhianu 2014).
In osteoarthritic conditions, the chondrocytes are no longer able to maintain homeostasis between synthesis and degradation of cartilage extracellular matrix (Heijink et al. 2012) . First, the damaged cartilage changes its mechanical properties, and it becomes thinner and more fragile. Over a period of time, the cartilage thins to total destruction, and the subchondral bone is revealed by this process. Changes in the bone tissue result in the loss of trabecular bone, bone marrow lesions, abnormal remodelling, and sclerotic changes. These changes are probably influenced by growth factors that are released from the synovial fluid. It is still not clear whether the process of cartilage and subchondral damage occurs simultaneously or separately (Man and Mologhianu 2014) . Besides these changes, it is possible to detect hyperplasia and inflammation of the synovial membrane (Brandt et al. 2008) , the presence of proinflammatory cytokines and damage of the menisci (Pauli et al. 2011) .
Osteoarthritis is a widespread degenerative joint disorder, which can be alleviated in its earlier stages by medication; however, in its later stages a total joint replacement can be desirable.
Vascular anatomy and physiology
Blood vessels (i.e. arteries and veins of various diameters) are composed of three concentric layers: tunica intima, tunica media, and tunica adventitia. The thickness of each of the layers varies among individual blood vessel types.
Tunica intima (intima) is the inner layer, which comes into direct contact with the blood flow. This layer is composed of a monolayer of polygonal endothelial cells (ECs), the basal membrane, connective tissue, and there may also be a supportive internal elastic lamina (in the arterial wall).
Tunica media (media) is the middle layer of blood vessels. It is composed of vascular smooth muscle cells (VSMCs) and fibroblasts, each of them produce the extracellular matrix.
The extracellular matrix is composed mainly of elastic and collagen fibres.
Tunica adventitia (adventitia, tunica externa) is the external layer of blood vessels. The adventitia is composed of fibroblasts, collagen connective tissue and, in arteries, also of external elastic lamina. The adventitia is also a source of pericytes (in capillaries and microvessels) and adventitial cells (around large vessels), which are, in fact, multipotent mesenchymal stem cells able to differentiate into various cell types (Corselli et al. 2012) .
Physiologically, the endothelial layer is continuous and intact, and is composed of mature ECs. The properties of ECs are as follows: (i) non-proliferating, (ii) non-thrombogenic, (iii) non-immunogenic, and (iv) rich in secreting various molecules. The secreted molecules can regulate the blood flow (e.g. endothelin, angiotensin, NO, prostacyclins), haemocoagulation (e.g. von Willebrand factor, tissue factor, trombomodulin, prostacyclins), the growth of vascular smooth muscle cells (e.g. fibroblast growth factor -FGF, platelet-derived growth factor -PDGF, heparin, transforming growth factor -TGF, epidermal growth factor -EGF), and the production of extracellular matrix, particularly heparin-like glycosaminoglycans, which keep the VSMCs in their quiescent, non-proliferative and differentiated contractile phenotype (Pometlová et al. 2015 ; for a review, see .
Pathophysiology of degenerative vascular damage
The pathophysiology of vascular damage is usually associated with a dysfunction of endothelial cells. Atherosclerosis is a frequent chronic inflammation of the intima layer, in which the aetiology of the endothelial dysfunction is multifactorial. There are mechanical insults, e.g. hypertension, and chemical insults, e.g. low density lipoproteins (LDL), glucose, homocysteine, uric acid, oxygen radicals, which are responsible for pro-vasoconstrictive, procoagulative, pro-inflammatory, and pro-proliferative pathways (Pometlová et al. 2015) .
The increased release of biologically-active molecules from the endothelium (PDGF, FGF, and EGF) also stimulates VSMCs in proliferation, and abnormal migration from the media layer into the subendothelial layer. At the same time, the VSMCs lose their contractile proteins (alpha-actin, myosin heavy chain), and their metabolism in cell organelles is focused more on proteosynthesis. In other words, VSMCs gain a dedifferentiated phenotype, referred to as synthetic phenotype (Sung et al. 2005 , Fager et al. 1989 ).
These mechanisms lead to thickening of the arterial wall. The lumen of the artery becomes thinner and restricts the blood flow. The atheroma plaque can become unstable, and after a haemocoagulation cascade is activated on its surface, it can cause thrombotic occlusion in the damaged artery. An embolism from unstable atherosclerotic plaque can also occur. Although prevention and pharmacological treatment are often successful, replacement is sometimes unavoidable, due to irreversible damage to the artery (Chlupáč et al. 2009 ).
Regenerative medicine, tissue engineering and biomaterials
Regenerative medicine is a multi-disciplinary field that combines findings from biology, chemistry, physics, medicine, and computer science. The following sections will cover all four main groups of stem cells, with special emphasis on adult mesenchymal stem cells -adipose tissue-derived stem cells.
Stem cells

Embryonic stem cells
Embryonic stem cells (ESCs) are defined as cells derived from the inner cell mass of preimplantation stage blastocyst, 5-7 days after fertilization (Gaskell et al. 2016) . These cells have great potential for regenerative therapies because of their pluripotency (i.e. their ability to differentiate into a cell of any type in the human body) and their limitless proliferation capacity.
Although the therapeutic potential of ESCs could be high, the procedure for obtaining them is difficult due to the ethical law in many countries, and the harvested cells are available only in limited quantities. Moreover, as the pluripotent potential of these cells is so high, the potency to teratoma formation also seems to be non-negligible (Ben-David and Benvenisty 2011).
Fetal stem cells
Fetal stem cells ( , Kim et al. 2004 , Kögler et al. 2004 , Yang et al. 2004 ). In some papers, these are treated as adult stem cell sources, as the origin of the tissue is both maternal and fetal.
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Nowadays, stem cells of umbilical cord blood origin can be banked for future allogenic or autologous cellular therapies, especially for umbilical cord blood transplantation in hematologic disorders (for a review, see Brunstein and Wagner 2006, Ballen et al. 2013) . According to the current definition, MSCs are multipotent cells that are able to differentiate into cells of mesodermal lineages, e.g. bone, cartilage and adipose cells (Pittenger et al. 1999 , Uccelli et al. 2008 , Wuchter et al. 2016 . Furthermore, their differentiation capacity is broader in in vitro cultures, depending on the chemical composition of the medium, the mechanical properties of the scaffold, and the dynamic cultivation conditions. Nowadays, bone marrow stem cells (BMSCs) and adipose-derived stem cells (ASCs) are most widely studied among MSCs, and they are being tested in many in vitro and in vivo studies on regenerative medicine and cell-based therapy. Current and previous clinical trials have been registered by the U.S. National Institutes of Health (https://www.clinicaltrials.gov).
Adult mesenchymal stem cells
Bone marrow stem cells
Bone marrow stem cells (BMSCs) were the first MSCs to be successfully isolated, characterized in detail and used widely in regenerative medicine as a source of adult stem cells.
Bone marrow is usually aspired from the sternum or from the pelvic area as a diagnostic method for blood diseases or during a bone marrow transplantation procedure. This procedure is uncomfortable and painful for patients, and they produce only limited yields of isolated BMSCs. Nevertheless, the multipotent potential and the adult origin of BMSCs ensure that they are considered as a suitable source at least for bone and cartilage tissue engineering. There have been studies using the direct effect of BMSCs on cartilage regeneration in osteoarthritic knees (Wakitani et al. 2002 , Yamasaki et al. 2014 and in wound healing (Wu et al. 2007 . The interaction of BMSCs with a suitable scaffold, e.g. with silk (Meinel et al. 2005) or alginate (for a review, see Sun and Tan 2013), for repairing bone and cartilage has also been studied.
A detailed characterization of BMSC behaviour, their differentiation pathways, and their genome will later help us to understand the behaviour of MSCs. In addition, the characteristics of newly-described types of MSCs can be compared with these undoubtedly promising adult stem cell sources.
Adipose-derived stem cells
Adipose-derived stem cells (ASCs) are stem cells of adult origin that were first identified and described in 2001 as an alternative source of autologous or allogenous MSCs for tissue engineering (Zuk et al. 2001) . In many patients, ASCs are more abundant than BMSCs, and subcutaneous adipose tissue is easily accessible. ASCs can be harvested via liposuction under local anaesthesia. The tumescent liposuction procedure is a painless and reasonably comfortable way for patients to provide enough autologous stem cells. BMSCs and ASCs have a similar multilineage differentiation potential (Zuk et al. 2002 , Strem et al. 2005 , while the yields of stem cells and the proliferation capacity were observed to be higher for ASCs (Kern et al. 2006) .
In recent years, adult stem cell research has made huge progress in the field of cell-based therapy, and in regenerative medicine in general. The ASC secretome includes active molecules such as vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), basic fibroblast growth factor (bFGF), granulocyte colony-stimulating factor (G-CSF), interleukin 6 and 8 (IL-6, IL-8), nerve growth factor (NGF), hepatocyte growth factor (HGF), insulin-like growth factor-1 (IGF-1), brain-derived growth factor (BDNF), and glial-derived growth factor (GDNF) (for a review, see Banyard et al. 2015) . The future of ASCs offers direct use of their secretion of trophic factors, and also their multilineage differentiation potential In subsequent cell passages, it is necessary to perform phenotypical characterization of isolated cells to prove their mesenchymal origin. According to the International Society for Cellular Therapy, ASCs in a culture retain the following surface markers: CD90, CD73, CD105, and CD44 (>95%), and they lack CD45 and CD31 (<5%) (Bourin et al. 2013 ). In addition, advice has been given to test their multilineage potential for adipocytic, chondroblastic and osteoblastic differentiation in media supplemented by growth factors and other specific additives. 
Current and potential clinical applications of ASCs
Patient factors
In recent years, as the number of studies using ASCs in regenerative medicine has been rising, patient factors seem to be very important. So far, there have been several studies focusing on the association between ASC viability and various donor factors. Subsequent proliferation and differentiation capacity, which can be patient-dependent, has also been a topic of interest.
The main factors that can vary from patient to patient (i.e. gender, age, BMI, harvest site) are summarized in Table 2 (for a review, see Varghese et al. 2017) . Varghese et al. analysed 41 papers in which some of the patient factors showed significant differences. Besides these main factors, there are some studies that have suggested a potential influence of radiotherapy, chemotherapy, hormonal treatment, smoking, hypertension, diabetes mellitus, or renal disease on the properties of isolated ASCs (Varghese et al. 2017 ).
There are also factors resulting from ASC harvesting and isolation methods that can influence the quality and the further use of isolated ASCs ( Table 2) .
Induced pluripotent stem cells
Induced pluripotent stem cells (iPSCs) were first described by Takahashi and Yamanaka in 2006. The key step in iPSC production is the process of reprogramming mature differentiated cells into an embryonic-like state.
The advantages of iPSCs seem to be (i) their pluripotency, (ii) their potential for gene correction, and (iii) the fact that they are a relatively easily accessible source of autologous cells. However, Riggs et al. (2013) studied the differences in transcriptomes between iPSCs and in vitro produced tumor cells from the same fibroblast origin. They found a significant number of similar genes that were present either in iPSCs or in tumor cells. These results suggested similar processes while inducing pluripotency and tumorigenicity in mature cells.
Hence, similarly to pluripotent ESCs, the potential to form ectopic and tumorigenic tissue seems to be non-negligible, and needs to be further investigated in detail (Ben-David and Benvenisty 2011).
Differentiation of mesenchymal stem cells towards mature cells
Cells in in vitro cultures are influenced by various stimuli. In general, depending on the cell type, various stimuli can support the cells in changes of morphology, secretome, proliferation rate, and differentiation (Fig. 1) . If the culture conditions are not suitable for a specific cell type, apoptosis cascades can be triggered. Stem cells are particularly responsive to every stimulus, as it is natural for them to receive signals in vivo in the human body. The role of these signals is either to retain them in "stem condition" or to trigger differentiation into the desired phenotype. Different culture conditions can be used separately, or can be combined to multiply these effects.
Osteogenic differentiation
Because of their mesodermal origin, osteogenic differentiation in adult MSCs has been studied in detail. This origin suggests that it is a relatively easy type of differentiation, especially if these cells are isolated from the bone marrow.
The usual composition of the differentiation medium consists of a basal medium, a fetal bovine serum, antibiotics, ascorbic acid, β-glycerophosphate, and dexamethasone in various concentrations (for a review, see Liao and Chen 2014) . Variably, the medium can also be supplemented with vitamin D, L-glutamin, transforming growth factor-beta, and bone morphogenic proteins (for a review, see Vater et al. 2011) .
Osteogenic differentiation can also be supported by suitable biomaterial properties: i.e. adhesivity, stiffness, nanocrystalline structure and degradability (for a review, see Murphy et al. 2014) . In addition, the 3D structure of scaffolds seems to be more attractive for the cells, as it simulates the natural niche of cells.
In recent years, research has focused on dynamic conditions of in vitro cultures. For better simulation of the mechanical cues occurring in the human body, cyclic equiaxial stretching (Virjula et al. 2017) or vibration loading (Tirkkonen et al. 2011 , Zhou et al. 2011 ) have been applied to MSCs. The results have shown faster and higher osteogenic differentiation, while combining appropriate mechanical conditions with a suitable scaffold architecture and a suitable composition of the medium.
Smooth muscle cell differentiation
Differentiation into smooth muscle cells depending on the composition of the media has already been performed successfully. There are various growth factors and molecules that can support differentiation. Transforming growth factor beta 1 (TGF-beta1) was one of the first factors shown to have a positive influence on the formation of the alpha-actin, calponin, caldesmon, and myosin-heavy chain protein structures that are involved in smooth muscle cell differentiation. Studies have been made not only of TGF-beta1, but also of thromboxane A2, angiotensin II, sphingosylphosphorylcholin, ascorbic acid, platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and bone morphogenetic protein 4 (BMP4), in various combinations and concentrations (Narrita et al. 2008 , Kim et al. 2009 , Harris et al. 2011 , Brun et al. 2015 . Nevertheless, it should be taken into account that TGF-beta1 also supports the transition of fibroblasts to myofibroblasts, which are associated with various diseases, such as systemic sclerosis (Lafyatis 2014), pulmonary hypertension with subsequent right ventricular remodelling (He et al. 2017) , and particularly tumour diseases, such as melanoma (Kodet et al. 2018) or breast carcinoma (Kojima et al. 2010) . The proper differentiation effect of TGF-beta1 towards smooth muscle cell phenotype should be simultaneously supported by appropriate scaffolds and particularly by appropriate mechanical stimulation.
Smooth muscle cell differentiation is an aspect of "soft tissue engineering", and is supported by "soft" biomaterials. Basic components of extracellular matrix, i.e. type I collagen, poly-L-lysin or fibronectin (Cooper et al. 2011 , Sgarioto et al. 2012 ,Wei et al. 2014 , are used to compose or at least to coat biomaterials for faster cell adhesion and also for cell differentiation (Filová et al. 2014 ).
In the human body, blood vessels are exposed to permanent cyclic strain stress with an average frequency of 60 heartbeats per minute. These conditions have a positive influence on the differentiation of progenitor cells. Cyclic strain stress of amplitudes between 5 and 10% and with a frequency of 0.5 -1.5 Hz supports the differentiation pathways of stem cells into smooth muscle cells (Shimizu et al. 2008 , Rothdiener et al. 2016 .
Similarly to osteogenic differentiation, the differentiation of stem cells can be even faster and more successful when the effects of media composition, the properties of the biomaterial, and dynamic culture conditions are combined.
Substitutes used in bone tissue engineering
Many patients suffer from degenerative or traumatic diseases of the skeletal system. Current therapies in bone diseases are focused on autografts and allografts, or on the implantation of metal-or ceramic-based implants (Reichert et al. 2016) . The strategies for fabricating an appropriate biomaterial are directed at tissue conduction and induction. Tissue conduction refers to the migration of cells of a given tissue and blood vessel formation that can be reached in 3D scaffolds. An induction strategy refers to support for the proliferation and differentiation of progenitor cells to a desired phenotype (Reichert et al. 2016) . So far, bone grafts remain the best choice concerning osteoconductive and osteoinductive properties, i.e. they stimulate the ingrowth of osteoblasts inside the graft material and, at the same time, they induce differentiation of local stem cells into osteoblasts (García-Gareta et al. 2015) However, these grafts can be harvested only in limited quantities, and donor site morbidity also has to be taken into account.
In implant orthopaedic surgery, metallic biomaterials are still used as the "gold standard" for total joint replacements in patients suffering from osteoarthritis. Stainless steels, cobaltbased alloys, titanium alloys, and modifications to these alloys, have been widely used, though some of their physical and biological properties differ from those of healthy bone tissue (e.g. their Young's modulus, biocompatibility, osseointegration, corrosion, and wear) (for a review, see Saini et al. 2015) . Recently, some other metals have been involved in alloy preparation. NiTi shape-memory alloys, magnesium, tantalum, zirconium and silver have been studied, due to 
Substitutes used in vascular tissue engineering
Vascular grafting is a surgical procedure in which a damaged or occluded vessel is replaced by an autograft, an allograft, or a synthetic prosthesis. Human grafts can be of venous or arterial origin. They usually bestow good mechanical properties, high infection resistance and low antigenicity for patients. Although autografts are the first choice when replacing small or medium caliber vessels, smaller grafts less than 6 mm in diameter usually fail within 5 years after surgery (Leon and Greisler 2003) . Moreover, autografts and allografts are available only in limited quantities, due to the age of the patients and donor site morbidity.
Until now, vascular tissue engineering has used scaffolds with a polymer-based origin.
Polymer-based biomaterials are elastic, so they mimic the physical properties of vessels.
Various modifications of polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE) are used in blood vessel replacements (Kannan et al. 2005 , Chlupáč et al. 2009 ). These prostheses are non-degradable, and they are fabricated to be porous. However, possible disadvantages of synthetic vascular prostheses are limited incorporation, graft rejection, risk of infection, dilatation over time, and surface thrombogenicity (Chlupáč et al. 2009 ).
Non-degradable PET and PTFE are widely used, and there is a tendency to fabricate advanced bioartificial degradable scaffolds. These scaffolds (e.g. polyurethane, polylactide, polycapronolactone, and polyglycolide) could serve as a temporary structure for attaching the cells. The attached cells could start to produce new layers of the blood vessel, while the degradable scaffold would slowly resorb (for a review, see Venkatraman et al. 2008) . However, these biomaterials have inadequate mechanical properties (Ravi et al. 2009) , and the scaffold still degrades in the human body more rapidly than the blood vessel forms.
Another approach in vascular tissue engineering is to use biologically-based decellularized vessels of xenogeneic, e.g. porcine origin (Badylak 2004) . These grafts can be harvested in sufficient quantities. The optimal decellularization procedure can offer biocompatible scaffolds in which the properties are very similar to those of autografts, while the immunogenicity is very low due to the absence of xenogenous cells (for a review, see Tapias and Ott 2014).
Furthermore, decellularized grafts can later be ameliorated by coating them with type I collagen, fibrin or other proteins of the extracellular matrix that support cell adhesion, proliferation and differentiation (Filová et al. 2014) .
In order to improve the biocompatible properties of vascular replacements, there are strategies that attempt to combine autologous cells of different origin with either decellularized or synthetic material-based prostheses (Harris et al. 2011 , Quint et al. 2012 . This combination could provide high biocompatibility of the graft, suitable mechanical properties similar to those of autografts and, last but not least, easier availability of the grafts in sufficient quantities (for a review, see Murphy and Atala 2013). In our experiment, we studied the impact of FGF2 on the proliferation and osteogenic differentiation of ASCs. The cells in the 2 nd passage were cultured in Dulbecco´s Modified
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Eagle Medium (DMEM), supplemented with 10% fetal bovine serum (FS) and 10 ng/ml of FGF2. When the cells reached 80% confluence, the basal medium was replaced by osteogenic medium either with or without FGF2. The osteogenic medium was supplemented with dexamethasone (DXM), β-glycerophosphate (BGCP), ascorbic acid (AA), variably also with Lglutamin (L-GLU) and vitamin D3 (vit. D3) (for details of the composition, see Table 3 ). The basal medium without osteogenic supplements was used as a control. The cells were cultured for 27 days. On days 6, 13, 20, and 27, we performed a resazurin assay, an alkalinephosphatase (ALP) activity assay, immunofluorescence staining of type I collagen and osteocalcin, and used the PCR method to detect gene expression of ALP and osteocalcin in order to evaluate the proliferation potential and osteogenic differentiation of ASCs.
Surprisingly, our results showed that the proliferation rate estimated by the metabolic activity of the cells, measured by a resazurin assay, depended more on the addition of osteogenic supplements than on the addition of FGF2 (Fig.2) . This tendency was also proved by counting the cell number in the same time intervals (data not shown). The activity of ALP, considered as an early or mid-term marker of osteogenic differentiation, was revealed to be significantly higher in cells cultivated without FGF2 during differentiation (Fig. 3) . These results are in accordance with a study by Simann and colleagues, where they observed a negative effect of FGFs on ALP expression (Simann et al. 2017) . They also observed a negative correlation between FGF concentration and matrix mineralization. In our study, the gene expression of ALP increased in time. On day 6 and 13, the expression levels were higher in cells treated with osteogenic supplements without FGF2 (Fig. 4) . Immunofluorescence staining revealed positive staining for both type I collagen and osteocalcin in cells treated with osteogenic supplements.
On day 20, the highest gene expression of osteocalcin was measured in cells treated with osteogenic supplements and 5 ng/ml of FGF2 (Fig. 4) , which was the same as for immunofluorescence staining (Fig. 5) . The amount of calcium deposition on day 27 (data not shown) was also highest in the media with osteogenic supplements and 5 ng/ml of FGF2. These findings could suggest a potential benefit from lowering the FGF2 concentration during differentiation on late osteogenic markers. No significant benefit of a richer osteogenic medium (i.e., with L-GLU and vitamin D3) was observed in our study. The study was performed on ASCs from one patient. As discussed above, the proliferation and differentiation capacity of the cells may vary depending on patient factors. It would be impactful to apply this study to a larger number of ASCs from different patient donors, in order to see whether the tendency of the osteogenic markers is similar.
Conclusion
Tissue engineering is a very promising field for current and future regenerative medicine.
The incidence of degenerative disorders correlates positively with increasing life expectancy. 
Conflict of interest
There is no conflict of interest. 
2017)
Age  yields, proliferation and differentiation within  age of donor (Varghese et al. 2017) BMI  viable cells in some studies within BMI of donor, significant negative correlation between BMI and differentiation (Varghese et al. 2017) Procedure factors 
